FDG-PET improves accuracy of staging in
non-small cell lung cancer
• The sensitivity and specificity of staging reported in studies with
pathological confirmation:
– CT alone:
• sens. 64%
• spec. 74%
– PET + CT:
• sens. 83%
• spec. 91%
(Gambhir et al. 2001; J. Nucl. Med. 42:1S-93S)